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ABSTRACT
INTRO: High fat diets (HFD) ingested over long periods of time have been shown to
cause diet induced obesity leading to excessive adiposity and chronic low grade
inflammation. Here we have shown how differing levels of saturated fats (SF), which are
common storage fats, affect markers of inflammation and mitochondrial biogenesis. IL1β and TNF-alpha are pro-inflammatory cytokines that have been shown to increase with
a HFD, while molecular signalers, PGC-1alpha, cyt c, and SIRT1, related to
mitochondrial biogenesis have been shown to decrease. Despite the risks of consuming a
diet high in SF’s, consumers continue to buy energy dense foods that are well known to
cause metabolic dysregulation. METHODS: Male C57BL/6 mice were randomized into
groups (n=8/9) (AIN 76 A), (AIN 76 A mod), (6% HFD), (12% HFD), (24% HFD). Mice
were fed either HFD or LFD for 16 weeks. Body weights were measured weekly. At 20
weeks of age mice were sacrificed and brain parts (hypothalamus, hippocampus, and
cerebellum) were isolated for mRNA analysis of two inflammatory cytokines (IL-1β,
TNF-alpha), and three molecular signalers (PGC-1alpha, SIRT1, and cyt c) using QTPCR. RESULTS: High fat feeding increased the accumulation of mass and obesogenic
characteristics. Beginning at 12 weeks of age all HFD groups were different from control
(AIN 76 A) (P<0.05). Beginning at 17 weeks of age the 12% HFD group was different
from both the 6% and 24% HFD group. Gene expression of cyt c in the cerebellum
increased in the 6% HFD relative to control (P < 0.033) and gene expression of IL-1β in
the hypothalamus increased in the 12% HFD
iv

group relative to control (P <0.031). CONLU: These findings suggest that diets high in
saturated fat (6%, 12%, 24%), but the same in total fat (40%) leads to an increase in body
weight and obesogenic characteristics, with the largest difference in the 12% HFD group.
This was associated with increased IL-1β expression in the hypothalamus, while the 6%
HFD was associated with an increase in cyt c expression suggesting changes in
mitochondrial biogenesis in the cerebellum.
Obesity; Metabolism; Brain; Inflammation

v

TABLE OF CONTENTS
Dedication…………………………………………………………………………..iii
Abstract……………………………………………………………………………..iv
List of Figures………………………………………………………………………vii
Chapter 1: The Effects of a High Fat Diet on Mitochondrial Biogenesis and Inflammation
in the Brain
Introduction…………………………………………………………………2
Methods……………………………………………………………………..5
Results………………………………………………………………………8
Discussion…………………………………………………………………..10
Chapter 2: Thesis Proposal
Brief Rational………………………………………………………………21
Specific Aims………………………………………………………………22
Proposed Model……………………………………………………………24
Literature Review………………………………………………………….25
References…………………………………………………………………………39

vi

LIST OF FIGURES
Figure 1.1: Body weight………………………………………………………………15
Figure 1.2: PGC-1alpha gene expression……………………………………………..16
Figure 1.3: SIRT1 gene expression…………………………………………………...17
Figure 1.4: Cytochrome C gene expression…………………………………………..18
Figure 1.5: IL-1 beta gene expression………………………………………………...19
Figure 1.6: TNF-alpha gene expression………………………………………………20
Figure 2.1: Proposed Model………….……………………………………………….24

vii

CHAPTER 1
THE EFFECTS OF A HIGH FAT DIET ON MITOCHONDRIAL BIOGENESIS
AND INFLAMMATION IN THE BRAIN1
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L. Vervaecke, J.M. Davis, J. Carson, A. Murphy, and R. Thompson. To be submitted to Obesity.
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INTRODUCTION
Obesity has become a large scale epidemic spanning the globe affecting both
adults and children causing severe health disparity and declines in quality of life. In the
United States alone, more than one third of all Americans are overweight or obese and
consume diets high in fat and excess calories (48). Many Americans suffer the ill-fated
effects associated with obesity such as cardiovascular disease, atherosclerosis,
hypertension, type 2 diabetes, fatty liver disease, and metabolic syndrome. The standard
American diet consists of 52% carbohydrate intake, 15% protein intake, and 33% fat
intake, of which 12% consists of saturated fats (SF) (23, 26). High fat diets (HFD)
ingested over long periods of time are well known to cause increased adiposity and
chronic low grade inflammation (37, 53). SF’s are well known storage fats that have
been linked to diet induced obesity and excessive adiposity thereby up regulating proinflammatory pathways instigating insulin resistance and metabolic dysregulation (34).
Despite the risks of consuming a diet high in SF’s, consumers continue to buy these
energy dense foods that are well known to cause metabolic dysregulation.
The majority of research that has assessed the effects of a HFD on mitochondrial
biogenesis has been done in skeletal muscle and adipose tissue. We know that energy
metabolism takes place in the mitochondria, the power house of the cell, and combines
oxygen and desired fuel substrates, fats and carbohydrates, to be broken down into
cellular energy in the form of adenosine triphosphate (ATP). These metabolic processes
are regulated allosterically by adenosine monophosphate activated protein kinase
(AMPK). AMPK is a regulator of mitochondrial biogenesis and is the primary pathway
regulating mitochondrial activity (22, 65). AMPK mediates actions of peroxisome
proliferator activated receptor gamma co-activator alpha (PGC-1alpha) and silent
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information regulator one (SIRT1). SIRT1 acts by deacetylation of PGC-1alpha, a master
regulator of mitochondrial biogenesis. SIRT1 has been shown to be a primary regulator
of fatty acid oxidative metabolism and acts to protect against diet induced metabolic
dysfunction (24).
Current research has demonstrated that chronic HFD’s negatively affect
mitochondrial capacity in skeletal muscle through dysfunctional enzymatic regulation
and declines in the activity of molecular signalers (1, 58). HFD’s have also been shown
to induce oxidative stress and insulin insensitivity in peripheral tissues (1, 10, 19, 27, 62,
68). Chronic inflammation has been linked as a key component in diet induced obesity
and has been shown to negate cellular interactions, insulin signaling, molecular signalers,
and normal cellular functioning (1, 7, 19). Two pro-inflammatory cytokines IL-1β and
TNF-alpha are responsible for activating the NFkB pathway inducing M1 macrophage
infiltration (56). M1 macrophages activate pro-inflammatory cytokines and reactive
oxygen species, which have been shown to cause mitochondrial collapse (25). A paucity
of research has been done to elucidate the effects of HFD’s on skeletal muscle; however,
there is a gap in understanding if similar molecular dysregulation in peripheral tissues is
observed within the brain and potentially the cause of mitchondrial dysregulation,
oxidative stress, and therefore cognitive impairment and central fatigue.
The apogee of the central nervous system (CNS) is the brain, which is composed
of highly complex centers that are innervated by neurons, which control a plethora of
activities including movement, metabolism, memory, information processing, problem
solving, mood and fatigue (40, 64). Dysfunctional neurogenic activity has been
associated with fatigue, psychological impairments and cognitive disorders (28, 43, 64,
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70). Alzheimer’s disease and age related dementia are two disorders that have been
correlated with diet induced obesity and have been the main focus of HFD studies in the
brain (43, 70). Diets high in SF’s and cholesterol have demonstrated declines in the
integrity of the blood brain barrier and severe gliosis throughout the hippocampus (21).
Over nutrition has also been linked to increased inflammation in hypothalamic neurons
(66). Recently it has been suggested that nutrient regulation by SIRT1 with a HFD was
reduced in the hippocampus adversely affecting memory function (28, 72). Mitochondrial
swelling has also been observed with an acute HFD and is believed to cause mitchondrial
dysregulation; however, molecular signalers and specific mitochondrial markers were not
analyzed (54).
Skeletal muscle has been copiously researched regarding changes in
mitochondrial capacity and inflammation with a HFD, but minute research is available
observing if similar changes take place within the brain. Mitochondrial signalers have
been shown to be important mediators in skeletal muscle metabolism, exercise
performance, delayed onset of fatigue, and endurance capacity, but are peripheral and
central activity similarly affected with a HFD? The purpose of this 16 week study was to
determine the effect of diets high in saturated fat (6%, 12%, 24%), but the same in total
fat (40%), on mitochondrial biogenesis and inflammation in the brain. Previous research
in our lab has shown that a HFD of 12% SF, the most similar to the standard American
diet, showed the greatest amount of adiposity, inflammation, and metabolic dysregulation
in peripheral tissues (17). We hypothesize that a HFD consisting of 12% SF will reduce
mitochondrial biogenesis and increase inflammation in the brain.
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METHODS
Animals
Male C57BL/6 mice were bred and cared for in the animal facility at the
University of South Carolina. They were housed, four-five per cage, maintained on a
12:12-h light-dark cycle in a low stress environment (22°C, 50% humidity, low noise)
and given food and water ad libitum. The Institutional Animal Care and Usage
Committee of the University of South Carolina approved all experiments.
Diets
Experiment 1: At four weeks of age, mice were randomly assigned to 1of 5
treatment diets (n=8-9/group): two control diets (CDs) (AIN-76A-1.6%-SF) (AIN-76AMod-1.7%-SF) and three HFDs (6%-SF, 12%-SF, and 24%-SF) (BioServ, Frenchtown,
NJ).The percentage of calories provided by each of the three macronutrients, the ratio of
polyunsaturated: monounsaturated fatty acids (PUFA:MUFA), and the ratio of omega6:omega-3 fatty acids were identical for the HFDs and were designed to be similar to the
standard American diet (26, 61). The second CD (AIN-76A-Mod) was used in order to
match the PUFA: MUFA and omega-6: omega-3 ratios of the HFDs.
Experiment 2: At four weeks of age mice were randomly assigned to 1 of 2
treatment diets (n=5-9/group): HFD (12%) or CD (AIN-76A) (BioServ, Frenchtown, NJ).
The percentage of calories provided by each of the three macronutrients, the ratio of
PUFA: MUFA and the ratio of omega-6: omega-3 fatty acids were designed to be similar
to the standard American diet (26, 61).
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Body weights, food intake, and body composition
Body weight (BW) and food intake were monitored weekly (experiment 1 and 2).
Body composition was assessed every four weeks (weeks 4, 8, 12, 16, and 20)
(experiment 1 only). For this procedure, mice were placed under brief anesthesia
(isoflurane) and were assessed for lean mass (LM), fat mass (FM), and body fat
percentage (BF %) via dual-energy x-ray absorptiometry (DEXA) (Lunar PIXImus,
Madison, WI).
Tissue collection
At 20 weeks of age, mice were sacrificed for tissue collection. The brain was
dissected out into 7 sections: brain stem, cerebellum, cortex, frontal lobe, hippocampus,
midbrain, and the hypothalamus. All tissues extracted were immediately snap-frozen in
liquid nitrogen and stored at -80°C. Blood was collected from the inferior vena cava, and
centrifuged at 4,000 rpm for 10 min at 4°C. Plasma was aliquoted and stored at −80°C.
mRNA expression
Brain tissue (n =8/9) were homogenized under liquid nitrogen with a Polytron
(PT3100; Kinematica, Lucerne, Switzerland), and the quanidine thiocyanate method with
TRIzol reagent (Life Technologies, GIBCOBRL, Carlsbad, CA) was used to extract total
RNA. The extracted RNA (2.5ul of sample) was dissolved in diethylpyrocarbonate
treated water and quantified spectrophotometrically at 260nm wavelength. The 260:280
ratio was used to determine the quality of RNA; RNA with a ratio ˃ 1.6 was included in
the analysis. RNA was reverse transcribed into cDNA in a 50ul reaction volume
containing 19.25ul RNA (1.5ug) in RNase-free water, 5ul 10X RT buffer, 11ul 25mM
MgCl2, 10ul deoxy-NTP mixture, 2.5ul random hexamers, 1ul RNase inhibitor, and
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1.25ul multiscribe reverse transcriptase (50U/ul). Reverse transcription was completed at
25°C for 10 min, 37°C for 120 min, and 85°C for 5 min, followed by a quick chilling on
ice. Samples were stored at -20°C until subsequent amplification.
Quantification of real time PCR
Real time PCR analysis was carried out per manufacturer’s instructions (Applied
Biosystems, Foster City, CA) using TaqMan Gene Expression Assays. Amplification of
DNA as performed in 12.5ul TaqMan Universal PCR Master Mix (AmpliTaq Gold DNA
Polymerase, Passive Reference 1. Buffer, dNTPs; AmpEase UNG), 1ul cDNA, 9ul
RNase-free water, 1.25ul 18S primer (VIC), and 1.25ul primer (FAM) (for endogenous
references and target gene) in a final volume of 25ul/well. A MicoAmp 96 well reaction
plate was loaded with samples and run using an ABI Sequence Detection System.
Following 2 min at 50°C and 10 min at 95°C, plates were coamplifed by 40 repeated
cycles, with one cycle consisting of a 15-s denaturing step at 95°C and a 1 min
annealing/extending step at 60°C. The data were analyzed by ABI software using the
cycle threshold (CT), or the value calculated and based on the time at which the reported
fluorescent emission increases beyond a threshold level citing the cycle number at which
the cDNA amplification was first detected.
Quantification of mRNA expression
PGC-1alpha, SIRT1, cyt c, IL-1β, TNF-alpha expression were calculated using a
single calibrator sample to compare every known samples gene expression against.
Breifly, ∆CT [CT (FAM) – CT (VIC)] was calculated for each sample and the average ∆CT
of the control mice was then used as the calibrator sample. Initial exclusion criteria
consisted of FAM CT ≥ 40 and VIC CT ≤ 23 and results showed all samples CT values
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were VIC CT ≤15, and FAM CT ≥ 33. This analysis and quantification method has been
shown to yield similar results as the standard curve method.
Statistical analysis
Data regarding mitochondrial markers and inflammatory markers were analyzed
using a one-way analysis of variance (ANOVA) to observe changes between all groups.
Student Newman Keuls post hoc test was used to make comparisons where appropriate.
All data were analyzed using commercial software (SigmaStat, SPSS, Chicago, IL).
Statistical significance was set with an alpha value of P < 0.05. Data are presented as
mean (±SEM).
RESULTS
Diets
Mice were housed 4-5/ cage and caloric intake was assessed by the total amount
of food eaten divided by the number of mice per cage. Food and water intake was
measured weekly. In general, all HFD groups consumed similar food and water intake
throughout the 16 weeks of feeding relative to control.
Body weights
Body weights were measured weekly to determine changes in total body weight in
regards to the differing ratios of saturated fat in the diet [Figure 1.1]. Body weight
measurements taken show that HFD increases the accumulation of mass and obesogenic
characteristics. Beginning at 12 weeks of age all HFD groups were different from control
(AIN 76 A) (P<0.05). Beginning at 13 weeks of age all HFD groups were different from
control (AIN 76 A mod) (P<0.05). By weeks 17-20 the 12% HFD group was
significantly greater in weight from both 6% HFD and 24% HFD (P<0.05).
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Gene expression for mitochondrial biogenesis
Gene expression of SIRT1, PGC-1alpha, and cyt c were examined in the
hypothalamus, hippocampus, and cerebellum portions of the brain. PGC-1alpha
expression showed no differences between groups in all three portions of the brain
[Figure 1.2]. SIRT1 expression was measured in the hippocampus and cerebellum, but
not in the hypothalamus due to limited reagents. Despite changes observed in the
literature with HFD, no significant differences were found between groups [Figure1.3].
When examining cyt c, we found an increase in gene expression within the 6% HFD
relative to control (AIN 76 A) (1.64±0.28) vs. (1.00±0.07) (P <0.033), but no differences
were seen in cyt c gene expression in the 12% and 24% HFD relative to control [Figure
1.4]. We measured two markers of mitochondrial biogenesis including SIRT1 and PGC1alpha, which are molecular signalers involved in stimulating mitochondrial biogenesis
and also cyt c, which is an enzyme in the electron transport chain associated with
mitochondrial adaptation. Overall it was shown that the metabolic signalers associated
with mitochondrial biogenesis were not significantly altered by16 weeks of high fat
feeding, however, unexpectedly, cyt c was increased with high fat feeding only in the
cerebellum.
Gene expression for inflammation
Gene expression of IL-1β and TNF-alpha were examined in the hypothalamus,
hippocampus, and cerebellum regions of the brain. TNF-alpha expression showed no
significant group differences in any of the three brain regions [Figure1.6]. However, IL1β a mediator of TNF-alpha through IL-1 receptor signaling, which activates the NFkB
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pathway, was found to be significantly higher in the 12% HFD group compared to
control (AIN 76 A) (2.108±0.330) vs. (1.00±0.06) (P < 0.031) [Figure 1.5].
DISCUSSION
It has been well established that diet induced obesity by HFD is commonly
associated with increased risk of cardiovascular disease, diabetes, and many other
pathologies due to the accumulation of adipose tissue leading to chronic inflammation,
thereby causing metabolic dysregulation. Skeletal muscle has been copiously researched
to elucidate the extent of oxidative stress, fatigue, inflammation, and metabolic
dysregulation, however, the brain is still poorly understood in regards to these same
developments. The purpose of this 16 week study was to determine the effect of diets
high in SF (6%, 12%, 24%), but the same in total fat (40%), on mitochondrial biogenesis
and inflammation in the brain. In general all HFD groups increased in size and body
mass; however, the 12% HFD group showed an increase in mass independent of the 6%
and 24% HFD group [Figure 1.1]. Previous research in our lab has shown that a diet of
12% SF, the most similar to the standard American diet, observed the greatest amount of
adiposity, inflammation, and metabolic dysregulation in peripheral tissues (17). Despite
similar characteristics in function between central and peripheral tissues, the brain shows
disparate outcomes in inflammation and mitochondrial capacity with a HFD. Our primary
finding was that the 12% HFD causes an increase in IL-1β expression in the
hypothalamus; a primary regulator of metabolism.
The first aim of our study was to elucidate how differing ratios of SF (6%, 12%,
24%) affect mitochondrial biogenesis in the brain. To do this we examined changes in
expression of two molecular signalers, SIRT1 and PGC-1alpha, and cyt c, an important
10

enzyme in the electron transport chain. Several studies have worked to examine the
effects of a diet high in fat on mitochondrial capacity in the brain; however, no studies
have been completed to determine, more specifically, how diets high in SF affect similar
variables. Brain HFD research has been primarily focused on Alzheimer’s disease and
age related dementia with the aim to determine how chronic ingestion of a HFD affects
memory consolidation and information processing. Recently it was shown that 23 weeks
of high fat feeding with 60% kcal coming from fat causes a decline in SIRT1 gene
expression in the hippocampus suggesting a decrease in mitochondrial biogenesis and a
subsequent decline in hippocampus-dependent memory (28). In discordance, our results,
after 16 weeks of high fat feeding with 40% kcal coming from fat and differing ratios of
SF (6%, 12%, 24%), show no change in SIRT1 across all groups [Figure 1.3]. Based on
previous research in our lab, we expected to see a decline in SIRT1 gene expression
within the 12% HFD, as we have shown it be the most metabolically dysregulating in
peripheral tissues (17). However, it is difficult to compare current literature citing a
change in SIRT1 gene expression due to differences in study duration; 16 versus 23
weeks, and diet composition; 40% versus 60% kcal (28).
We also assessed central mitochondrial biogenesis by examining changes in the
expression of PGC-1alpha. Our results show no change in PGC-1alpha with a 16 week
HFD [Figure 1.2]. Extensive literature is available regarding changes in PGC-1alpha in
skeletal muscle with a HFD; however, there are few studies that have looked similar
changes in the brain. Richardson et al. 2005 shows a decline in PGC-1alpha expression in
muscle tissue post 2 day lipid infusion (20% triglyceride emulsion, 30% kcal) in human
subjects (58). Although an 8 week intervention in mice suggests that a high fat feeding
11

with 47% kcal coming from fat, does not impede mitochondrial biogenesis, but in fact
enhances it with an increase in PGC-1alpha expression (29). In accordance with our
findings in the brain, Draznin et al. 2012 found no change in PGC-1alpha or other
mediators of mitochondrial biogenesis in skeletal muscle with a HFD (50% kcal) (16),
suggesting that duration and diet composition are major limitations to observing
mitochondrial changes with the induction of a HFD.
Cyt c was the final marker of examination to determine changes in mitochondrial
biogenesis. Cyt c is a component of the electron transport chain that is commonly used to
observe mitochondrial adaptations (39). Our results show an increase in cyt c expression
within the cerebellum of the 6% HFD group compared to control [Figure 1.4], suggesting
that mitochondrial biogenesis was increased with a HFD. However, we believe that this
may be an extraneous effect of medium versus long chain fatty acid breakdown, due to
the fact that no changes were observed in cyt c in the higher saturated fat groups; the 12%
HFD and the 24% HFD. Medium chain fatty acids are quickly transported and oxidized
within the body compared to long chain fatty acids, which are less efficiently oxidized
and more likely to be stored as adipose tissue (46).
There is a known link between diet induced obesity and systemic inflammation
and it has been suggested that central inflammation may be related to the development of
Alzheimer’s disease and age related dementia by neuronal dysfunction. The final aim of
our study was to examine how diets high in SF (6%, 12%, 24%) affect inflammation in
various regions of the brain. To our knowledge only one published study has reported
changes in the brain due to a diet high in SF. Findings describe alterations in the integrity
of the blood brain barrier of the hippocampus with increased microgliosis in HFD fed
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mice (45% kcal) (21). In addition Thaler et al. 2012 has shown that diet induced obesity
(60% kcal) causes inflammation in the brain with only 4 days of high fat feeding, where
as it takes weeks to observe inflammation in muscle (66, 67). Our results show an
increase in IL-1β in the hypothalamus in the 12% HFD group after 16 weeks of high fat
feeding, however, no changes were seen in the hippocampus or the cerebellum
[Figure1.5].
IL-1β mediates the up regulation of many other inflammatory cytokines like TNFalpha through IL-1 receptor signaling subsequently activating the NFkB pathway (45).
NFkB works to increase systemic lipolysis and glycogenolysis thereby increasing free
fatty acids and glucose in the blood that chronically results in insulin resistance. Despite
changes in IL-1β expression in the hypothalamus, we did not observe changes in TNFalpha expression across all groups in any of the examined brain parts. With regards to the
development of severe pathology related to diet induced obesity, such as metabolic
syndrome, the NFkB pathway is activated by low grade inflammation and chronically
orchestrates M1 machrophage infiltration that increases pro-inflammatory cytokines such
as TNF-alpha and IL-1β, as well as reactive oxygen species (56). This positive feedback
loop of inflammation has been shown to cause mitochondrial damage and collapse as
well as cellular apoptotic responses (25). The severity of the injury will dictate the time
frame in which inflammatory cytokines are up regulated, some injuries necessitate more
time than others.
In conclusion, this is the first study to examine the effects of differing levels of
SF’s on mitochondrial biogenesis and inflammation in the brain. We can conclude that
diets high in SF (6%, 12%, 24%), but the same in total fat (40%) lead to an increase in
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body weight and obesogenic characteristics, with the largest difference in the 12% HFD
group, which was associated with increased hypothalamic IL-1β expression, a marker of
inflammation. The 6% HFD group was associated with changes in mitochondrial
biogenesis in the cerebellum. It should be taken into consideration that in this study and
others, these responses are highly dependent upon the amount of SF in the diet and total
calories from fat. Limitations in this study include duration of the HFD and diet
composition. This study has provided a basic understanding of how diets high in SF
affect mitochondrial biogenesis and inflammation in the brain, future research is
warranted to determine specific timelines in which mitochondrial biogenesis is affected
along with changes in the normal inflammatory response.
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Figure 1.5: The effect of saturated fat on IL-1beta gene expression in HFD fed mice.
Gene expression (IL-1beta) for all groups is reported from the time of sacrifice, 20 weeks
of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 12% HFD
(12% n=6), 24% HFD (24% n=6). *Significantly different from control diet (AIN 76 A),
P<0.05. Values are reported as mean ± SE.
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Figure 1.6: The effect of saturated fat on TNF-alpha gene expression in HFD fed
mice. Gene expression (TNF-alpha) for all groups is reported from the time of sacrifice,
20 weeks of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6),
12% HFD (12% n=6), 24% HFD (24% n=6). No significant differences were found.
Values are reported as mean ± SE.
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CHAPTER 2
THESIS PROPOSAL
BRIEF RATIONAL
More than one third of all Americans are overweight or obese and consume diets
high in saturated fat, many of which suffer the ill-fated effects associated with obesity
such as hypertension, type 2 diabetes, and metabolic dysfunction. Energy metabolism in
the form of cellular respiration takes place in the mitochondria, the power house of the
cell, and combines oxygen and fuel sources such as fats, carbohydrates, and proteins to
be catabolized into cellular energy in the form of adenosine triphosphate (ATP). All
metabolic functions require the use of ATP to sustain activity and to carry out daily
processes. Muscle being a highly plastic organ can store fats and carbohydrates as
intramuscular triglycerides (IMTG) and glycogen. The standard American diet consists of
52% carbohydrate intake, 15% protein intake, and 33% fat intake of which 12% consists
of saturated fat. Sparks et al. 2006 has elucidated that diets high in saturated fat and
overall total fat have negative effects on energy metabolism in skeletal muscle
mitochondria related to dysfunctional enzymatic regulation and mitochondrial biogenesis,
as well as gene expression controlling glucose metabolism and storage. Chronic
inflammation related to obesity has also been shown to negate cellular interactions,
insulin signaling, enzymatic regulators, and normal cellular functioning. However,
minute research has been completed observing if similar changes take place within the
brain.
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The apogee of the central nervous system (CNS) is the brain, which is composed
of highly complex centers that control processes like movement, sight, hearing, emotions,
and metabolism. The hypothalamus, hippocampus, motor cortex, cerebellum, and brain
stem are the primary controllers of these bodily functions. Glucose being the primary fuel
source within the CNS is responsible for neurogenic activity. Astrocytes are glial cells
that are positioned between blood vessels and neurons that control energy metabolism in
the brain by feeding glucose to neurons. Neurons within the CNS control a plethora of
activities including attention, memory, information processing, problem solving,
impaired mood, and fatigue. Dysfunctional neurogenic activity has been associated with
fatigue, psychological impairments, and cognitive disorders related to malfunctions
within the astrocytes in the hypothalamus and the hippocampus, but what is causing this.
To date skeletal muscle has been highly researched regarding changes in
mitochondrial activity and glycogen storage with the manipulation of a high fat diet, but
minute research has been completed observing if similar changes take place within the
brain. Mitochondria and glycogen, as well as their subsequent regulators, have been
shown to be important mediators in skeletal muscle regarding energy metabolism and
endurance capacity, but are peripheral and central activity similarly affected with a high
fat diet?
PURPOSE AND SPECIFIC AIMS
The purpose of this 16 week study was to determine the effect of diets high in
saturated fat (6%, 12%, 24%), but the same in total fat (40%), on mitochondrial
biogenesis and inflammation in the brain. Previous research in our lab has shown that a
diet of 12% saturated fat, the most similar to the standard American diet, observed the
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greatest amount of adiposity, inflammation and metabolic dysregulation in peripheral
tissues.
Aim1: To determine the effects of a high fat diet (6%-SF, 12%-SF, 24%-SF) and
(40%) total fat on mitochondrial biogenesis in the brain.
We hypothesize that a high fat diet of 12%-SF will reduce mitochondrial
biogenesis in the brain. We will use RNA isolation and real time PCR to measure gene
expression of PGC-1alpha, SIRT1, and cytochrome c in the hippocampus, hypothalamus,
and cerebellum.
Aim 2: To determine the effects of a high fat diet (12%-SF) and (40%) total fat on
inflammation in the brain.
We hypothesize that a high fat diet of 12%-SF will increase inflammation in the
brain. We will use RNA isolation and real time PCR to measure gene expression of IL-1β
and TNF-alpha in the hippocampus, hypothalamus, and cerebellum.
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PROPOSED MODEL

High Fat Diet
6%-SF, 12%-SF, 24%-SF

Increased
inflammation,
reactive O2 species

Decreased
mitochondrial
signaler function

Neuronal
Injury

Decreased mitochondrial
biogenesis

Figure 2.1: This study is aimed to uncover the proposed model of a diet high in saturated
fat (6%, 12%, 24%), but the same in total fat (40%) on the effects of mitochondrial
biogenesis and inflammation in the brain. Based on previous research it is theorized that
the 12% saturated fat diet, the diet most similar to the standard American diet, will
observe the most mitochondrial dysfunction related to changes mitochondrial signaler
regulation in combination with increased inflammation and neuronal injury therefore
potentiating CNS impairment.

24

LITERATURE REVIEW
Energy Metabolism
Metabolism is the summation of all cellular work occurring at random within the
body, but more specifically, energy metabolism is a cyclic response of turnover and
synthesis to sustain usable energy (40). Cellular energy can be derived in two ways:
through aerobic pathways or anaerobic pathways. Anaerobic pathways are up regulated at
the beginning of all activity and do not use oxygen to synthesize cellular energy (39).
However, the aerobic pathway is a high capacity energy producer that utilizes oxygen to
combust fuels for energy (39). Fuel sources for energy metabolism are derived from
three major sources, fats, carbohydrates, and proteins, each source acting in cooperation
with the others to sustain bodily function. These macromolecules in combination with
oxygen in the aerobic pathway are transported to the mitochondria, the power house of
the cell, to be combusted into usable energy in the form of adenosine triphosphate (ATP)
(3).
Dependent upon cellular energy demands desired substrates will be selected to
form ATP. Carbohydrates are the primary fuel source during intense exercise and there
stored form as glycogen acts as a metabolic regulator for fatigue, while fats and proteins
are the desired fuel sources at rest (39). Energy substrates travel within the blood stream
until extraction or deposition occurs. Glucose can be extracted from the blood via insulin
or by cellular glucose transporters (GLUT) (68). Fatty acids bind to carrier
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proteins in the blood, like albumin or even insulin, and are transported to the cell for
utilization or storage (39). Fats and carbohydrates work cooperatively to maximize
energy production. Fats are oxidized in a residual carbohydrate metabolism allocating
glycogen sparing; therefore delaying the onset of fatigue (39). Protein degradation for
ATP synthesis is only used in highly fasted states. All substrates can be combusted for
the production of cellular energy or they can be stored within the body for later usage in
common sites such as: skeletal muscle, adipose tissue, liver, and the brain. However,
substrate utilization and storage are highly regulated by metabolic enzymes on a minute
by minute basis.
Regulation
Storage and utilization of energy substrates is dependent upon cellular energy
demand and subsequent metabolic regulating pathways. Adenosine monophosphate
activated protein kinase (AMPK) acts as a local energy sensor and regulates
mitochondrial biogenesis and overall metabolism through allosteric mechanisms (8, 16,
40). Allosteric regulation of metabolism is controlled through AMPK based on a
continuum of caloric intake from a fed state to a fasted state and on cellular energy levels
meaning, when energy levels are low the AMPK pathway is activated and when energy
levels are high AMPK activity declines. Peroxisome proliferator activated receptor
gamma coactivator alpha (PGC-1alpha) and sirtuins one (SIRT1) are key signaling
molecules that are allosterically mediated within the AMPK pathway that intrinsically
regulates mitochondrial activity and mitochondrial biogenesis. In a fasted state the
AMPK pathway is activated by the release of glucagon thereby stimulating SIRT1 via
cAMP cascade, which deacetylates PGC-1alpha, increasing fatty acyl CoA
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dehydrogenase and carintine acyletransferase, driving mitochondrial biogenesis and
oxidative capacity of long and short chain fatty acids (1, 16, 50). PGC-1alpha is
considered to be a “master regulator" of mitochondrial biogenesis in skeletal muscle and
has been shown to up regulate fatty acid metabolism and energy expenditure within the
mitochondria, as well as to improve insulin sensitivity in times of stress (22, 65). SIRT1
and PGC-1alpha acting in corporation enhance fatty acid metabolism by increasing the
gene expression of metabolites used in oxidative metabolism, however, fat metabolism
has been shown to be down regulated in SIRT1 knockout models citing the requirement
of SIRT1 for mitochondrial oxidative capacity (22). Cytochrome c (cyt c) and citrate
synthase (CS) are two mitochondrial molecular signalers that reside within the inner
membranes of the mitochondria and electron transport chain (ETC) and dictate metabolic
energy flow through electron acceptance during oxidative metabolism (39). When
metabolic demand increases chronically, as with exercise training, mitochondria are
stimulated for local division increasing mitochondrial density, which can be observed by
expression of mitochondrial DNA (mtDNA). Regulation of metabolism can be affected
by various external stimuli including exercise and diet. Diets high in fat leading to
obesity have been shown to negatively affect enzymatic regulation and cause metabolic
dysfunction.
High fat diets
Over the last 20 years, across all age groups, obesity rates have risen due to lack
of daily physical activity and the over consumption of energy dense foods. In 2010 the
United States had more than 1/3 of all adult Americans classified as obese with a body
mass index (BMI) greater than or equal to 30kg/m2 (48).The standard American diet
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consists of 52% carbohydrate, 15% protein, 33% fat with 12% coming from saturated fat,
a ratio of 1.8 to 1 monounsaturated to polyunsaturated fat, and a ratio of 20 to 1 omega 6
to omega 3 (23, 26, 61). In 2013 the trend for obesity continues as the amount of
saturated fat intake increases. Saturated fats (SF), commonly referred to as palmitic and
stearic acid, are known storage fats that are linked to dietary obesity and excessive
adiposity. Foods high in SF include red meats, many dairy products like cheese and
whole milk, pork, fast food and processed foods (69). SF’s have been shown to instigate
pro-inflammatory pathways via NFkB and can cause insulin resistance and dysregulation
in metabolic enzymes (34). Many side effects of diets high in saturated fat have been
linked to fatty liver disease, diabetes, cardiovascular disease, hypertension, metabolic
syndrome and many other health disparities.
Other types of HFD’s include polyunsaturated fat diets (PUFA) and
monounsaturated fat diets (MUFA). PUFA’s, particularly omega-6 and omega-3, are
related to healthy fat intake by consuming foods such as fish, soy products, and nuts (57).
MUFA’s are similar to PUFA’s compositionally, but MUFA’s can be obtained through
oils such as canola and olive (23). MUFA’s have been shown to attenuate the effects of a
diet high in saturated fat, but negates normal metabolic activity when combined with high
PUFA diets (23).
Researchers are now comparing similar diets in animal and human models to
represent the population to determine how local diets are affecting energy metabolism. A
predominate amount of calories are proportioned from fats to observe similar caloric
intake patterns of the standard American to determine if a HFD has any effect on energy
metabolism and substrate utilization. Diets consisting of 35-40% fat are commonly used
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and have been shown to attenuate insulin sensitivity (41) therefore leading to declines in
glycogen synthesis (10) and metabolism of fatty acids by PCG-1alpha stimulation (65).
Overall, it has been shown that excessive fat intake is linked to serious metabolic
dysregulation in the body, with lipid accumulation causing oxidative stress within the cell
leading to declines in glucose uptake, pre-empting fatigue (58, 60, 71). Excessive lipid
accumulation by a HFD over stimulates the cell causing increased reactive oxygen
species (ROS), thereby causing oxidative stress and increasing inflammation potentially
leading to dysfunctional enzymatic and molecular signaling activity. This phenomenon
has been highly researched in skeletal muscle.
High Fat Diet and Skeletal Muscle
Skeletal muscle is the primary location for oxidative metabolism of glucose and
lipid substrates, which also makes it a prime location to experience metabolic
dysregulation during times of stress. HFD’s can act as a metabolic stressor by inducing
an overload on the body with excess lipid accumulation and altered signaling of AMPK
(1, 19) causing localized oxidative stress and fatigue. Diets high in SF have been shown
to impair insulin sensitivity and enzyme regulation by causing severe inflammation
through the NFKB pathway increasing inflammatory cytokines IL-6 and TNF-alpha (32,
33). Diets high in SF have also been shown to decrease PGC-1alpha activity thereby
reducing oxidative phosphorylation of lipids (11, 34). AMPK and PGC-1alpha gene
expression have been shown to increase with the acute manipulation of a HFD and
concomitantly SIRT1 gene expression is up regulated to enhance fatty acid metabolism
during times of metabolic stress, thereby increasing mitochondrial biogenesis driving
energy metabolism in times of low demand (1, 19, 22).
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However, long term manipulations of a HFD have shown the opposite effects on
AMPK, with a decline in activity (24). Chronic ingestion of a high fat diet is well known
to cause insulin insensitivity. With reduced glucose uptake by insulin, glycogen synthesis
in skeletal muscle is reduced potentially leading to metabolic fatigue. Therefore, with
chronic lipid accumulation both carbohydrate and lipid uptake are halted and
subsequently reduced by obesity related insulin insensitivity; that may be correlated with
inflammation (27, 51, 68). Cleasby et al. 2011 has demonstrated with a five week HFD in
mice, a reduction in both insulin sensitivity and glycogen synthesis in skeletal muscle
(10). Sparks et al. 2006 found a similar response in a three week HFD study (62).
Previous research completed in our lab has shown that 16 weeks of a high fat diet with
12% saturated fat, the most similar to the standard American diet, shows the greatest
amount of adiposity, inflammation, and subsequent metabolic dysregulation in peripheral
tissues (17). Through extensive review of the literature it can be noted that the effects of a
HFD on skeletal muscle metabolism and enzymatic regulation has been well researched,
however, results have yet to be definitively addressed.
Differences in Metabolic Function
Oxidative phosphorylation has been shown in several studies to be affected by the
manipulation of a HFD; some studies cite an increase in mitochondrial oxidative capacity
with increased lipid availability, while others cite the reverse effects. Length of the
manipulation, the amount of SF, the total amount of fat intake, and molecular makeup of
fat are potential parameters affecting the dichotomous outcomes. Iossa, S. et al. 2002
demonstrated that two weeks of a HFD enhanced mitochondrial oxidative capacity
utilizing lipids as the primary fuel source (30). Lionette, L. et al. 2007 and Hoeks, J. et al
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2008 observed similar findings in a seven and eight week HFD study respectively (29,
38). Lionette used 50% energy intake from lipids with a PUFA to saturated fat ratio of
1.7 (38) and Hoeks used 47% energy intake coming from lipids (29). However, longer
manipulations of a high fat diet have elucidated the reverse effects. Enos et al. has shown
that 16 weeks of a high fat diet with 40% energy intake coming from lipids and 12%
saturated fat shows the greatest amount of adiposity and subsequent metabolic
dysregulation, disparately saturated fat amounts independent of total fat shows the
opposite effects with 24% saturated fat displaying the lowest levels of metabolic
dysregulation and even normal mitochondrial function (17). Enos and colleges state a
potential mechanism in molecular differences between long and short chain fatty acids.
Gomes et al. completed a 12 week HFD study and found declines in mitochondrial
enzymatic and molecular signaling activity, but used a similar diet to Lionette and
colleges at 60% energy intake coming from lipids (24). This finding suggests that length
of the HFD and chronic ingestion of lipids is the main contributor to metabolic syndrome.
However, these dichotomous outcomes related to duration of study and amount of total
fat and SF have not been thoroughly explained in the literature and future research is
warranted.
In summary current research has shown with the manipulation of a HFD that
regulation of AMPK becomes dysfunctional subsequently altering allosteric regulation of
PGC-1alpha, SIRT1, and insulin decreasing homeostatic metabolic function in skeletal
muscle. Excessive lipid accumulation causes oxidative stress on the cell affecting normal
metabolism of fuel substrates. Chronically glucose and lipid substrate utilization and
storage becomes impaired and mitochondrial biogenesis declines. There is copious
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evidence displaying the negative effects of a HFD on skeletal muscle metabolism,
however, we have yet to elucidate how metabolism and mitochondrial biogenesis is
affected with a HFD in the central regulator of our body, the brain.
Brain
The brain is the apogee of the CNS and is divided into white and grey matter in
four primary lobes: occipital, temporal, frontal, and parietal, which are then divided into
smaller subsections (40). The subsections are responsible for controlling complex
processes involving motor function, decision making, metabolism, mood, information
processing, and regulating energy and fatigue through neuronal communication (40). The
medulla oblongata and pons are regions of the brain stem. Both regions control motor and
sensory function in the body. The medulla oblongata specifically controls autonomic
responses including respiratory, cardiovascular and digestive functioning (40). The
hippocampus is part of the limbic system that involves memory storage and information
retrieval (40). The cerebellum controls bodily movement; consciously and
subconsciously (40).The hypothalamus is the central regulator of all metabolism
controlling hunger and thirst in “feeding centers” and “satiety centers” with hormonal
responses that can stimulate glucose and lipid uptake, utilization, and storage (6).
The brain utilizes and stores energy substrates to carry out basic daily processes.
Contrary to skeletal muscle, the brain does not metabolize lipids as an energy substrate,
but growing evidence sites the “sensing” of fatty acids to dictate hormonal signaling (36,
57). Glucose is the primary energy substrate in the brain that is utilized by neurons and
stored in astrocytes, which accounts for 99% of all ATP production (20, 55). Astrocytes
are connected to neurons by capillary networks that allow glucose to move freely for
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energy usage. Similar to skeletal muscle, the brain uses GLUT receptors, specifically
GLUT1, 3, to transport glucose from the blood across the neuronal membrane for direct
utilization by the neuron or storage in the astrocyte where glycogen is primarily localized
(14, 15, 55). Astrocytic glycogen is the only source of glycogen storage in the brain, but
compared to skeletal muscle storage is insignificant (15).
The brain functions primarily under aerobic metabolism using mitochondria to
oxidize glucose for energy due to the limited glycolytic capacity of the CNS (9, 43).
Neuronal stimulation is activated via sodium release, coupled by glutamine reuptake,
which stimulates glucose metabolism in the brain (55). Brain glucose metabolism in
neurons is regulated via AMPK, which mediates molecular signaling of SIRT1 and PGC1alpha, thereby regulating insulin (74). AMPK also moderates nutrient usage and
hormonal regulation (4, 42).
Hormone release, regulated by the hypothalamus, contributes stimulatory affects
to the uptake, storage, and utilization of glucose under different physiological states. In a
stressful physiological state, metabolic demand changes and redirects blood flow to high
demand tissues. For example, during exercise blood flow is redistributed away from the
gut to the skeletal muscle, the heart, skin, and the brain (39). Exercise training enforces
chronic adaptations of increased delivery of oxygen and nutrients, oxidative capacity and
mitochondrial biogenesis to accommodate the increasing metabolic demands (63). Post
exercise, blood flow returns to trivial areas, but remains elevated in both skeletal muscle
and brain at 20% and 14% respectively (39). Exercise is not the only physiological
stressor that can induce changes in metabolic function and mitochondrial biogenesis;
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stress originating from the intake of a high fat diet also leads to serious metabolic
disturbances.
High fat diet and brain metabolism
The CNS operates on glucose metabolism within the mitochondria with little to
no oxidation of fatty acids. Despite this fact, research has shown that a diet high in fat can
cause metabolic dysregulation not only in peripheral tissues, but central tissues as well.
Memory deficits and cognitive impairments are the most commonly studied phenomenon
related to brain function with a HFD. Alzheimer’s and age related dementia are two areas
of research that have been linked to diet induced obesity and oxidative stress (43, 70).
The hippocampus has been highly researched in regards to memory deficits and age
related dementia due to its primary function of memory retrieval, storage and information
processing. A recent study suggests that memory deficits are correlated to a decline in
SIRT1 gene expression in the hippocampus of HFD fed mice (28). A decline in SIRT1
may be indicative of reduced metabolic function and cellular energy production (28).
Diets high in SF’s and cholesterol have been demonstrated to reduce the integrity of the
blood brain barrier and cause severe gliosis throughout the hippocampus (21).
Throughout the brain insulin sensitivity is relatively low compared to skeletal
muscle; however, in the hypothalamus insulin sensitivity is high allowing mediation of
systemic hormone regulation. Insulin activity via hypothalamic signaling allows fatty
acids to be stored in a process called lipogenesis by down regulating the sympathetic
nervous system output to adipose tissue (59). Hypothalamic injury in accordance with
excess lipid accumulation will disrupt normal insulin activity and sensitivity and may
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eventually lead to over production of glucose through gluconeogenic pathways and
subsequently type 2 diabetes (59).
Over nutrition by a HFD has been shown to induce mitochondrial dysfunction in
hypothalamic neurons with a decline in central glucose sensitivity (49). Morphologic
measurements of mitochondria post HFD have revealed mitochondrial swelling that
negated mitochondrial membrane potential, especially during oxidative stress (54). This
finding suggests that oxidative stress may be leading to mitochondrial dysfunction and a
decline in energy metabolism preempting metabolic fatigue. Oxidative stress is also a
primary factor to the induction of inflammation by diet induced obesity and the increase
in fat cell size and number (5).
High fat diet and inflammation
HFD’s have been shown to take weeks to incite inflammation and dysfunctional
metabolic regulation in skeletal muscle, however, in the brain it can be observed within
24 hours, with neuronal injury and impairment in the hypothalamus within the first week
(66). HFD’s have been shown to cause an increase in adipose tissue, which provides a
storage site for fat and acts as a production site for inflammatory cytokines such as
interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNF-alpha) (18). As
adipocytes grow in size and number with a HFD, inflammatory cytokine production
progressively worsens provoking systemic inflammation. The CNS blocks inflammatory
cytokines from entering the brain through the blood brain barrier making it immune from
peripherally instigated inflammation. However, the brain activates various inflammatory
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transcription factors, increasing cytokines, in response to local and systemic
inflammation (67).
TNF-alpha was one of the first major cytokines discovered within the
inflammatory pathway. Its production from immune cells, skeletal muscle, and adipose
tissue propagates a wide systemic response. Unlike other pro-inflammatory cytokines,
TNF-alpha instigates obesity by acting as a potent activator of fatty acid release through
the NFkB pathway and it inhibits the initiation of receptor substrates for insulin signaling
(18). Lack of response by insulin can lead to an accumulation of free fatty acids and
glucose in the blood thereby reducing glycogen storage.
TNF-alpha is also mediated through IL-1β, a known pro-inflammatory cytokine
that stimulates the up regulation of other inflammatory cytokines through IL-1 receptor
signaling thereby activating the NFkB pathway (45). IL-1β has recently been shown in the
literature to be associated with Alzheimer’s disease progression and other neurological
disorders by affecting brain astrocytes and neuronal communication (45). Thaler and
colleges have shown an up regulation of IL-1β and TNF-alpha in response to diet induced
obesity over 4 weeks (66). Once inflammatory cytokines have infiltrated a tissue the
overwhelming response is to activate other cytokines to the area stimulating further
progression of pro-inflammatory processes leading to destruction of a tissue.
Research has shown that chronic inflammation from HFD’s causes oxidative
stress instigating the increase in reactive oxygen species (ROS) (2, 7). ROS are common
byproducts produced during metabolism, but can increase severely during times of
oxidative stress and mitochondrial damage (39). ROS can also cause mutations in
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mtDNA inducing mitochondrial collapse (25). The inflammatory cascade may be
involved in every aspect of metabolic oxidative stress due to the chronic inflammatory
response with a HFD. Current research on HFD’s has developed managerial treatments
for reducing inflammation and fatigue, while increasing insulin sensitivity, but no formal
cures have been discovered.
Potential treatments
Consuming a diet high in fat is well known to cause adiposity and low grade
chronic inflammation. This inflammation may be the primary cause of insulin
insensitivity in both the brain and skeletal muscle. HFD induced oxidative stress caused
by excessive lipid accumulation has also contributed to what seems to be irreversible
affects on energy metabolism. Improving quality of life and life longevity is the primary
reason for research on human pathophysiology. Quercetin is a supplement that is found in
many food sources such as fruits and vegetables and has been shown to work through
anti-inflammatory pathways (13). Our lab has shown the effective use of Quercetin in
enhancing brain and muscle mitochondrial biogenesis that stimulated increases in
endurance capacity and voluntary activity in mice (13).
Resveratrol is similar to Quercetin in that it is found in common everyday foods
like red wine and grapes and has been associated with elimination of free radicals and
reversal of insulin resistance and diet induced obesity (75). Jeon et al. 2012 has shown
that resveratrol can attenuate inflammation and improve memory deficit in obesity
induced diabetic mice (31). Resveratrol has also been shown to increase neurogenesis and
brain-derived neurotrophic factor in the hippocampus (44).
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More recently the health community has been trying to implement exercise as a
prescription for improving health disparity rather than prescribing medication. The
American College of Sports Medicine has incited “Exercise is Medicine” and continues
to excite interest in prescribing personalized treatment through exercise. Exercise is
multifunctional in that several modes exist: resistance training, swimming, running,
biking, walking, tennis, baseball, etc. producing similar effects allowing subjects to
choose the most enjoyed form available that is consistently overloading the body to elicit
adaption. Currently it has been shown that chronic exercise training can attenuate obesity
related insulin insensitivity by reducing excess lipid accumulation and enhancing
signaling for glucose uptake and utilization in skeletal muscle (52).
Conclusion
In summation, a diet high in fat not only causes peripheral distress, but it also
causes central dysregulation. The extent of central oxidative stress on metabolic function
has yet to be fully elucidated. Morphologic observation on mitochondria and changes in
insulin sensitivity with hypothalamic injury by HFD has been assessed; however,
regulation of metabolism through enzymatic function has yet to be researched beyond
SIRT1. Future research linking obesity to metabolic dysregulation, changes in
mitochondrial biogenesis, and inflammation is warranted.
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